$24.8 M

OVAS Mkt cap, 07-Dec-2018

$81 K

OvaScience Revenue Q2, 2018
OvaScience Gross profit (Q2, 2018)27 K
OvaScience Gross profit margin (Q2, 2018), %33.3%
OvaScience Net income (Q2, 2018)-7.7 M
OvaScience EBIT (Q2, 2018)-7.9 M
OvaScience Cash, 30-Jun-201824.6 M

OvaScience Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017

Revenue

277.0k653.0k295.0k

Cost of goods sold

2.2m5.4m790.0k

Gross profit

(2.0m)(4.7m)(495.0k)

Gross profit Margin, %

(712%)(727%)(168%)

R&D expense

15.8m18.4m21.6m18.3m

General and administrative expense

13.3m51.6m49.2m27.7m

Operating expense total

29.1m72.3m81.7m50.9m

EBIT

(29.1m)(72.0m)(81.0m)(50.6m)

EBIT margin, %

(25992%)(12406%)(17155%)

Interest expense

436.0k659.0k

Interest income

90.0k436.0k659.0k752.0k

Pre tax profit

(73.1m)(82.1m)(50.9m)

Income tax expense

75.0k201.0k67.0k

Net Income

(29.0m)(73.2m)(82.3m)(51.0m)

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Revenue

15.0k30.0k75.0k146.0k189.0k197.0k63.0k67.0k81.0k

Cost of goods sold

1.2m1.2m269.0k112.0k54.0k

Gross profit

(1.0m)(1.0m)(206.0k)(45.0k)27.0k

Gross profit Margin, %

(705%)(552%)(327%)(67%)33%

R&D expense

4.7m4.5m5.3m5.7m4.0m4.0m6.0m6.0m5.0m5.8m2.6m2.4m

General and administrative expense

3.0m5.1m11.0m13.1m12.9m14.5m11.2m12.6m7.1m4.2m2.6m

Operating expense total

7.7m9.6m12.4m16.8m17.1m16.9m21.6m18.4m17.6m14.7m7.6m8.0m

EBIT

(7.6m)(9.6m)(12.4m)(16.8m)(17.2m)(17.8m)(21.4m)(18.2m)(19.0m)(14.6m)(7.6m)(7.9m)

EBIT margin, %

(112087%)(57247%)(23696%)(14684%)(9651%)(9626%)(23154%)(11316%)(9758%)

Interest expense

57.0k27.0k25.0k101.0k141.0k

Interest income

101.0k141.0k174.0k161.0k182.0k191.0k224.0k

Pre tax profit

(21.7m)(18.5m)(19.2m)(14.9m)(7.4m)(7.7m)

Income tax expense

75.0k50.0k92.0k9.0k

Net Income

(7.8m)(9.9m)(12.9m)(17.2m)(17.5m)(17.9m)(21.8m)(18.6m)(19.3m)(14.9m)(7.4m)(7.7m)

OvaScience Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

18.1m6.4m43.2m43.9m15.7m

Accounts Receivable

Inventories

650.0k1.6m3.0m2.1m

Current Assets

45.1m61.9m129.9m116.4m68.8m

PP&E

880.0k3.4m8.3m5.6m3.1m

Total Assets

47.5m65.6m138.6m122.5m72.9m

Accounts Payable

1.7m2.5m3.4m2.2m2.2m

Short-term debt

Current Liabilities

5.8m10.2m11.2m13.2m7.8m

Long-term debt

Total Debt

Total Liabilities

5.8m11.8m14.3m8.6m

Additional Paid-in Capital

86.9m150.0m294.9m358.4m365.8m

Retained Earnings

(94.7m)(167.9m)(250.2m)(301.5m)

Total Equity

41.7m55.3m126.9m108.2m64.3m

Financial Leverage

1.1 x1.2 x1.1 x1.1 x1.1 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Cash

56.1m16.6m12.1m134.7m70.2m50.8m20.5m95.9m50.5m25.4m19.7m24.6m

Current Assets

90.1m82.6m73.6m171.3m159.2m145.3m112.7m150.1m133.5m101.2m59.1m54.2m

PP&E

1.2m1.9m3.1m4.2m4.2m6.7m8.7m8.1m8.0m4.7m2.9m403.0k

Total Assets

92.8m85.8m77.5m175.8m164.5m152.8m122.1m158.7m142.4m106.3m63.0m55.5m

Accounts Payable

1.9m1.4m3.0m2.5m3.0m4.2m4.2m2.5m2.8m2.4m1.0m757.0k

Current Liabilities

6.3m7.1m8.8m6.6m7.6m9.9m11.8m10.7m11.3m10.6m5.0m4.7m

Total Liabilities

6.4m7.1m8.9m13.2m12.2m11.6m5.7m5.3m

Additional Paid-in Capital

139.4m141.6m144.4m281.0m286.2m289.9m298.5m354.8m357.4m360.1m366.2m366.7m

Retained Earnings

(75.8m)(111.9m)(129.4m)(147.3m)(189.7m)(208.2m)(227.5m)(265.4m)(308.8m)(316.6m)

Total Equity

86.4m78.7m68.6m169.1m156.7m142.6m108.8m146.6m129.9m94.7m57.3m50.2m

Financial Leverage

1.1 x1.1 x1.1 x1 x1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x

OvaScience Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(29.0m)(49.5m)(73.2m)(82.3m)(51.0m)

Depreciation and Amortization

231.0k450.0k1.3m2.2m1.7m

Accounts Receivable

Inventories

Accounts Payable

(721.0k)2.3m(171.0k)(1.2m)68.0k

Cash From Operating Activities

(18.1m)(30.6m)(50.3m)(61.7m)(45.6m)

Purchases of PP&E

(719.0k)(2.8m)(5.2m)(2.6m)(158.0k)

Cash From Investing Activities

(11.0m)(32.8m)(38.3m)8.3m

Cash From Financing Activities

32.4m51.7m125.4m54.1m

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(7.8m)(17.7m)(30.6m)(17.2m)(17.5m)(17.9m)(21.8m)(40.3m)(19.3m)(14.9m)(7.4m)(15.1m)

Depreciation and Amortization

66.0k148.0k262.0k504.0k1.1m461.0k330.0k506.0k

Accounts Payable

1.4m1.2m1.9m2.5m3.0m4.2m378.0k(921.0k)2.8m184.0k(1.4m)(1.5m)

Cash From Operating Activities

(5.0m)(11.5m)(20.1m)(15.4m)(31.3m)(15.2m)(8.9m)(13.8m)

Purchases of PP&E

(1.2m)(1.5m)(370.0k)(868.0k)

Cash From Investing Activities

(8.6m)(41.6m)(37.4m)(7.3m)29.9m(3.3m)13.0m22.7m

Cash From Financing Activities

51.7m51.6m51.6m54.1m

OvaScience Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information

OvaScience Employee Rating

3.411 votes
Culture & Values
3.4
Work/Life Balance
3.6
Senior Management
3.0
Salary & Benefits
3.3
Career Opportunities
3.1
Source